Allogene Therapeutics, Inc. (ALLO)
2.78
+0.05
(+1.83%)
USD |
NASDAQ |
Feb 27, 16:00
2.66
-0.12
(-4.32%)
After-Hours: 06:48
Allogene Therapeutics Research and Development Expense (TTM) : 153.96M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| Agenus, Inc. | 105.60M |
| Curis, Inc. | 31.40M |
| LadRx Corp. | 0.7712M |
| Plus Therapeutics, Inc. | 7.624M |